World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance From Food Animal Production.

Antimicrobial use in food animals selects for antimicrobial resistance in bacteria, which can spread to people. Reducing use of antimicrobials-particularly those deemed to be critically important for human medicine-in food production animals continues to be an important step for preserving the benefits of these antimicrobials for people. The World Health Organization ranking of antimicrobials according to their relative importance in human medicine was recently updated. Antimicrobials considered the highest priority among the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins, macrolides and ketolides, and glycopeptides. The updated ranking allows stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on drugs used in food animals that are the most important to human medicine. In particular, the current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently.

[1]  D. Paterson,et al.  Colistin resistance: a major breach in our last line of defence. , 2016, The Lancet. Infectious diseases.

[2]  Luke S P Moore,et al.  Antimicrobials: access and sustainable eff ectiveness 2 Understanding the mechanisms and drivers of antimicrobial resistance , 2015 .

[3]  Jianzhong Shen,et al.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. , 2015, The Lancet. Infectious diseases.

[4]  J. Kluytmans,et al.  Trends in extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae and ESBL genes in a Dutch teaching hospital, measured in 5 yearly point prevalence surveys (2010-2014) , 2015, Antimicrobial Resistance and Infection Control.

[5]  P. Collignon,et al.  China, what antibiotics and what volumes are used in food production animals? , 2015, Antimicrobial Resistance and Infection Control.

[6]  Marius Gilbert,et al.  Global trends in antimicrobial use in food animals , 2015, Proceedings of the National Academy of Sciences.

[7]  B. Guerra,et al.  An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. , 2014, Veterinary microbiology.

[8]  Edward Topp,et al.  The scourge of antibiotic resistance: the important role of the environment. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. D. Kraker,et al.  The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  J. Mandal,et al.  Antibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli , 2012, The Indian journal of medical research.

[11]  J. Turnidge,et al.  Control of Fluoroquinolone Resistance through Successful Regulation, Australia , 2012, Emerging infectious diseases.

[12]  Maliha Aziz,et al.  Staphylococcus aureus CC398: Host Adaptation and Emergence of Methicillin Resistance in Livestock , 2012, mBio.

[13]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[14]  D. Livermore,et al.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. , 2011, The Lancet. Infectious diseases.

[15]  P. Davey,et al.  Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. , 2011, The Journal of antimicrobial chemotherapy.

[16]  P. Collignon,et al.  Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  Qixing Zhou,et al.  Occurrence and source analysis of typical veterinary antibiotics in manure, soil, vegetables and groundwater from organic vegetable bases, northern China. , 2010, Environmental pollution.

[18]  V. Enne.  Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? , 2010, The Journal of antimicrobial chemotherapy.

[19]  Hui Wang,et al.  Residues of veterinary antibiotics in manures from feedlot livestock in eight provinces of China. , 2010, The Science of the total environment.

[20]  L. Ng,et al.  Ceftiofur Resistance in Salmonella enterica Serovar Heidelberg from Chicken Meat and Humans, Canada , 2010, Emerging infectious diseases.

[21]  Y. Carmeli,et al.  Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Yongli Zhang,et al.  Prevalence of Antibiotic Resistance in Drinking Water Treatment and Distribution Systems , 2009, Applied and Environmental Microbiology.

[23]  F. Aarestrup,et al.  World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. Aarestrup,et al.  Resistance in bacteria of the food chain: epidemiology and control strategies , 2008, Expert review of anti-infective therapy.

[25]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[26]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[27]  Stephan Harbarth,et al.  Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes , 2004, Emerging infectious diseases.

[28]  T. Pruett.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America , 2010 .